Diseases, Conditions, Syndromes

Severe lung infection during COVID-19 can cause damage to the heart

SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a study has found. The research, published in the journal Circulation, specifically looked at damage to the ...

Medications

Drug design at the atomic level to thwart COVID-19

Although COVID-19 has faded from the headlines, SARS-CoV-2—the coronavirus behind the pandemic—is still rampantly infecting people around the world. Public health officials fear as the virus continues to evolve, it will ...

Medical research

Long COVID may harm cognition

In a finding that unearths yet another way Long COVID can harm health, new research finds the condition may trigger thinking declines.

Diseases, Conditions, Syndromes

COVID-19: A potential treatment for loss of smell

One of the most persistent and debilitating symptoms of COVID-19 is anosmia or loss of smell. Researchers at INRAE and ENVA have discovered that a corticoid treatment could help restore the olfactory capacities affected by ...

Vaccination

Annual two-dose SARS-CoV-2 vaccination campaign beneficial

Annual administration of a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine five months after the initial dose results in fewer hospitalizations and deaths, according to a study published ...

page 1 from 2

Severe acute respiratory syndrome

Severe Acute Respiratory Syndrome (SARS; pronounced /sɑrz/, sarz) is a respiratory disease in humans which is caused by the SARS coronavirus (SARS-CoV). There has been one near pandemic to date, between the months of November 2002 and July 2003, with 8,096 known infected cases and 774 deaths (a case-fatality rate of 9.6%) worldwide being listed in the World Health Organization's (WHO) 21 April 2004 concluding report. Within a matter of weeks in early 2003, SARS spread from the Guangdong province of China to rapidly infect individuals in some 37 countries around the world.

Mortality by age group as of 8 May 2003 is below 1% for people aged 24 or younger, 6% for those 25 to 44, 15% in those 45 to 64 and more than 50% for those over 65. For comparison, the case fatality rate for influenza is usually around 0.6% (primarily among the elderly) but can rise as high as 33% in locally severe epidemics of new strains. The mortality rate of the primary viral pneumonia form is about 70%.

As of May 2006[update], the spread of SARS has been fully contained thanks to the efforts of the WHO, with the last infected human case seen in June 2003 (disregarding a laboratory induced infection case in 2004). However, SARS is not claimed to have been eradicated (unlike smallpox), as it may still be present in its natural host reservoirs (animal populations) and may potentially return into the human population in the future.

This text uses material from Wikipedia, licensed under CC BY-SA